Equillium, Inc. · NASDAQ:EQ
Equillium — Fact Sheet (October 2020)
2 slides from Equillium's fact sheet, Oct 25, 2020
Slide 1: A Clinical Trial for Your Patients with Lupus or Lupus Nephritis
A CLINICAL TRIAL FOR YOUR PATIENTS WITH LUPUS OR LUPUS NEPHRITIS The EQUALISE Clinical Trial The EQUALISE trial is currently enrolling patients with lupus and lupus nephritis at sites in the United States, with plans to open additional sites outside of the U.S. in 2020. This Phase 1b study will eval
Slide 2: equilliuay
-_ equilliuay ——~_ FY”